Robin L. Avila

1.5k total citations
37 papers, 1.2k citations indexed

About

Robin L. Avila is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robin L. Avila has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 10 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robin L. Avila's work include Multiple Sclerosis Research Studies (12 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Hereditary Neurological Disorders (6 papers). Robin L. Avila is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Hereditary Neurological Disorders (6 papers). Robin L. Avila collaborates with scholars based in United States, Italy and Germany. Robin L. Avila's co-authors include Daniel A. Kirschner, Xinghua Yin, Grahame J. Kidd, Ana I. Flores, S. Priya Narayanan, H. Elizabeth Shick, Wendy B. Macklin, Hideyo Inouye, Pedro Brites and Adrienne Luoma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Robin L. Avila

36 papers receiving 1.2k citations

Peers

Robin L. Avila

CMN

NEURO

Colleen T. Harrington United States

Lidia De Filippis Italy

Kazuhiko Namikawa Japan

Marie‐Stéphane Aigrot France

Andrew V. Caprariello Canada

An‐Chi Tien United States

Ana Bribián Spain

Joshua Murtie United States

Andrew A. Jarjour Canada

Colleen T. Harrington United States

Robin L. Avila

857 ×1.6

401 ×1.1

CMN

464 ×1.3

90 ×0.5

196 ×1.1

NEURO

Citations per year, relative to Robin L. Avila Robin L. Avila (= 1×) peers Colleen T. Harrington

Countries citing papers authored by Robin L. Avila

Since Specialization

Citations

This map shows the geographic impact of Robin L. Avila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Avila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Avila more than expected).

Fields of papers citing papers by Robin L. Avila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Avila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Avila. The network helps show where Robin L. Avila may publish in the future.

Co-authorship network of co-authors of Robin L. Avila

This figure shows the co-authorship network connecting the top 25 collaborators of Robin L. Avila. A scholar is included among the top collaborators of Robin L. Avila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin L. Avila. Robin L. Avila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perumal, Jai, Roumen Balabanov, Laura J. Balcer, et al.. (2023). Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis. Neurology and Therapy. 12(3). 833–848. 2 indexed citations

Mendoza, Jason P., et al.. (2023). COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy. Neurology and Therapy. 12(2). 687–700. 8 indexed citations

Avila, Robin L., et al.. (2023). Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis. Journal of Infusion Nursing. 46(6). 347–359. 2 indexed citations

Perumal, Jai, Roumen Balabanov, Roger Chang, et al.. (2022). Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study. CNS Drugs. 36(9). 977–993. 9 indexed citations

Houtchens, Maria K., Andrea I. Ciplea, Nancy Ramia, et al.. (2022). Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 60. 103700–103700. 6 indexed citations

Cohan, Stanley, Barry Hendin, Anthony T. Reder, et al.. (2021). Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex). CNS Drugs. 35(7). 743–767. 1 indexed citations

Reder, Anthony T., et al.. (2021). Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 51. 102935–102935. 4 indexed citations

Houtchens, Maria K., Andrea I. Ciplea, Nancy Ramia, et al.. (2020). Interim analysis of peginterferon beta-1a in the breast milk of lactating patients with multiple sclerosis (2790). Neurology. 94(15_supplement). 1 indexed citations

Avila, Robin L., He Huang, Thomas C. Leeper, et al.. (2017). Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation. Biochemistry. 56(10). 1518–1528. 35 indexed citations

10.

Luoma, Adrienne, Fonghsu Kuo, Özgür Çakıcı, et al.. (2015). Plasmalogen phospholipids protect internodal myelin from oxidative damage. Free Radical Biology and Medicine. 84. 296–310. 73 indexed citations

11.

Avila, Robin L., Jing Wang, Emily Benson, et al.. (2015). Fingolimod reduces axonal transection during demyelination (P1.153). Neurology. 84(14_supplement). 4 indexed citations

12.

Zeldich, Ella, Ci-Di Chen, Robin L. Avila, Satish Medicetty, & Carmela R. Abraham. (2015). The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination. Journal of Molecular Neuroscience. 57(2). 185–196. 48 indexed citations

13.

Gilardini, Alessandra, Robin L. Avila, N Oggioni, et al.. (2011). Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy. NeuroToxicology. 33(1). 1–7. 26 indexed citations

14.

Avila, Robin L., Maurizio D’Antonio, Angela Bachi, et al.. (2010). P0 (Protein Zero) Mutation S34C Underlies Instability of Internodal Myelin in S63C Mice. Journal of Biological Chemistry. 285(53). 42001–42012. 19 indexed citations

15.

Avila, Robin L., et al.. (2009). Internodal myelination during development quantitated using X-ray diffraction. Journal of Structural Biology. 168(3). 521–526. 24 indexed citations

16.

Flores, Ana I., S. Priya Narayanan, H. Elizabeth Shick, et al.. (2008). Constitutively Active Akt Induces Enhanced Myelination in the CNS. Journal of Neuroscience. 28(28). 7174–7183. 298 indexed citations

17.

Luo, Xiaoyang, Hideyo Inouye, Deepak Sharma, et al.. (2007). Cytoplasmic Domain of Zebrafish Myelin Protein Zero: Adhesive Role Depends on β-Conformation. Biophysical Journal. 93(10). 3515–3528. 7 indexed citations

18.

McNally, Melanie A., Rena Baek, Robin L. Avila, et al.. (2007). Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis. Journal of Negative Results in BioMedicine. 6(1). 8–8. 7 indexed citations

19.

Avila, Robin L., et al.. (2006). Myelin Structure and Composition in Zebrafish. Neurochemical Research. 32(2). 197–209. 34 indexed citations

20.

Avila, Robin L., Hideyo Inouye, Rena Baek, et al.. (2005). Structure and Stability of Internodal Myelin in Mouse Models of Hereditary Neuropathy. Journal of Neuropathology & Experimental Neurology. 64(11). 976–990. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact